123690 — Hankook Cosmetics Co Balance Sheet
0.000.00%
Last trade - 00:00
- KR₩107bn
- KR₩96bn
- KR₩79bn
- 81
- 27
- 13
- 31
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 13,327 | 25,797 | 12,939 | 12,120 | 15,068 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 15,232 | 6,757 | 4,500 | 4,225 | 6,079 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 43,019 | 47,005 | 29,987 | 27,907 | 33,684 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 19,071 | 13,751 | 7,744 | 4,741 | 3,270 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 81,308 | 75,378 | 48,508 | 43,913 | 48,624 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 37,785 | 40,392 | 23,490 | 19,363 | 21,859 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 46,115 | 45,893 | 26,508 | 21,280 | 23,069 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 35,193 | 29,485 | 22,001 | 22,634 | 25,556 |
Total Liabilities & Shareholders' Equity | 81,308 | 75,378 | 48,508 | 43,913 | 48,624 |
Total Common Shares Outstanding |